Significats de cardiac rejection en anglès

Molecular technologies have evolved in recent years, deciphering pathophysiology of cardiac rejection.

Likewise, patients with cardiac rejection after heart transplantation showed increased cardiac miR-21 levels.

Acute cardiac rejection remains an important cause of death during the first year following cardiac transplantation.

There was no difference between the two groups in the incidence of mild or moderate episodes of cardiac rejection.

The convenience and lower cost of oral prednisone therapy may warrant its routine use for this type of cardiac rejection.

Both patients are alive more than 1 year following transplant, with good cardiac and renal function and no signs of cardiac rejection.

Conflicting patterns of myocardial cell adhesion molecule expression associated with cardiac rejection have emerged from numerous studies of randomly selected cardiac biopsies.